or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 80 drug resistance PhD Projects, Programmes & Scholarships
drug resistance PhD Projects, Programmes & Scholarships
We have 80 drug resistance PhD Projects, Programmes & Scholarships
A new approach to understanding the role of tumour microenvironment in anticancer drug resistance
St George’s, University of London
MRC London Intercollegiate Doctoral Training Partnership Studentships
Melanoma is a type of skin cancer with the most rapidly growing incidence in the UK. In melanoma, like in many other cancers, the tumour microenvironment (TME) plays a critical role in driving anticancer drug resistance. Read more
Decoding the epigenetic mechanisms of drug resistance in aggressive breast cancers
Breast cancers pose a major health burden to modern world as being the most common cancer in women. Estrogen receptor (ER), the classical marker of 70% these cancers, is the nuclear receptor important for cancer progression. Read more
Using Covalent Inhibitors to Overcome Drug Resistance in Cutaneous Melanoma
This project is one of a number that are in competition for funding from the University of Bath URSA competition, for entry in September 2025. Read more
Evaluating the epidemiology, genetic basis and molecular evolution of antimicrobial drug resistance in Helicobacter pylori in a populational model
Antimicrobial Drug Resistance (AMR) is a growing and major public health threat facing the worldwide population within the next 30 years, imposing considerable burden on health systems. Read more
Combatting multidrug resistance: Are alpha-arrestins attractive therapeutic targets to tackle Candida infections?
The opportunistic fungal pathogen Candida glabrata is a frequent cause of candidiasis, causing infections ranging from superficial to life-threatening disseminated disease, and is associated with high mortality, especially in immunocompromised individuals. Read more
(MB-PhD) Multiomic investigation of drug resistance in lobular breast cancers
Lobular breast cancers represent one of the understudied cancers but of unmet need, due to their poor response to targeted therapies. Read more
Do nutrient availability and the extracellular matrix affect therapy response in cancer?
The tumour microenvironment (TME) plays a pivotal role in controlling cancer progression and response to therapy. A key component of the TME is the extracellular matrix (ECM), a complex network of secreted protein involved in controlling a variety of cell functions, including proliferation and migration. Read more
Development of novel drug combinations for improved treatment of cancers of unmet need
Research Group:
Centre for Skin Sciences
The cancer incidence in UK has risen by 39% over the last decade and advanced disease (metastasis) has poor overall five-year survival rate (5%). Read more
PhD Studentship in “Multi-scale mathematical models to predict prostate cancer progression and treatment response.”
Prostate cancer (PCa) ranks as the second most prevalent cancer among men worldwide, also constituting the fifth cause of cancer-related death. Read more
Cybergenetic control of living cells: a control-based approach to design new therapies
The project. Precision oncology promises to develop effective therapies tailored to the genetic profile of specific cancers. To achieve this goal, we still need to overcome drug resistance, which often arises in therapies targeting a single oncogenic driver. Read more
Nanotechnologies for cancer: developing new polymer-drug conjugates for the treatment of a range of cancers
Polymer anticancer-drug conjugates are drug delivery systems in which a low molecular weight anticancer agent is covalently conjugated to a water-soluble polymeric carrier. Read more
(Bicentenary) Tracking horizontal gene transfer and the spread of antimicrobial resistance in pathogenic fungi
Background. Antimicrobial resistance (AMR) is a major threat to human health, with a global rise in untreatable bacterial infections. Read more
Nanoprecision in antibiotic delivery using targeted nanoparticles
Gram-negative bacterial species, including E. coli, are major causes of infectious diseases worldwide and account for all organisms in the “critical” category of the WHO list of antibiotic-resistant "priority pathogens". Read more
MSc by Research / PhD: Farm to food to AMR: How do agriculture and food preservation practices affect fungal antimicrobial resistance?
The MSc by Research programme at the University of Aberdeen is for students interested in a research-intensive master's degree. It is designed specifically to enhance your skills for a PhD or research career. Read more
Fully funded PhD studentship in mechanisms of cancer heterogeneity and drug sensitivity
Treatment of cancer with drugs that cause DNA damage often leads to development of the drug tolerance. Recently, we uncovered a novel mechanism of such an adaptation that associates with active generation of hundreds of thousand mutations in chromosomes that prevent drug-triggered DNA damage. Read more